Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 15/20 | 0.52 |
| ▸ | ITGAV | P06756 | 15/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.52 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6969094 | 0.92 | ITGB3 (0.53) | ITGB3ITGAVITGA2BITGB5CASP1 | |
| SCHEMBL6964129 | 0.92 | ITGB3 (0.59) | ITGB3ITGAVITGA2BITGB5 | |
| Hydrochloric Acid SCHEMBL7659068 | 0.91 | ITGB3 (0.53) | ITGB3ITGAVITGA2BITGB5CASP1 | |
| SCHEMBL7224008 | 0.86 | ITGB3 (0.53) | ITGB3ITGAVITGA2B | |
| SCHEMBL7232314 | 0.86 | ITGB3 (0.52) | ITGB3ITGAVITGA2BITGB5CASP1 | |
| SCHEMBL7222557 | 0.84 | ITGB3 (0.38) | ITGB3ITGAVITGA2B | |
| SCHEMBL6978381 | 0.82 | ITGB3 (0.48) | ITGB3ITGAVITGA2B | |
| SCHEMBL7231335 | 0.82 | CASP1 (0.47) | ITGB3ITGA2BCASP1MAOA | |
| SCHEMBL7223767 | 0.80 | ITGB3 (0.54) | ITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL4838464 | 0.80 | ITGB3 (0.63) | ITGB3ITGAVITGA2BITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6458801-B1 | PHARMACEUTICALLY ACCEPTABLE SALTS AND ITS PRODRUG USEFUL FOR TREATING OSTEOPOROSIS. | AVENTIS PHARMA S.A. (FR) | 2002-10-01 | — | — | US | disclosed |